Explore Business Standard
Vaccine
You trust the data put out by the United Kingdom but not the figures given by the Indian government, the Supreme Court on Thursday told the petitioners who claimed that authorities reported "alarmingly low" number of deaths due to adverse effects of Covid vaccine. A bench of justices Vikram Nath and Sandeep Mehta was hearing arguments on the pleas including the one which alleged that two women lost their lives in 2021 after taking the first dose of Covishield vaccine. It was alleged that after vaccination, both of them suffered from severe adverse effects following immunization. The top court reserved its order in the matter. Senior advocate Colin Gonsalves, appearing for petitioners in one of the pleas, said the same vaccine was used in the UK and India administered 30 times more jabs as compared to the UK. "The difference is so large that there seems to be a worrying discrepancy between the UK, which is putting its data transparently, and India which is hiding the data of deaths,
Panacea Biotec Ltd on Thursday said it will supply bivalent oral polio vaccines worth Rs 127.2 crore to the Central Medical Services Society, Ministry of Health and Family Welfare. In a regulatory filing, Panacea Biotec said the Central Medical Services Society (CMSS) has accepted the company's offer for supply of bivalent oral polio vaccine against the tender issued by it through a Letter of Acceptance (LOA) dated October 8, 2025. "As per the LOA, the company will supply the vaccine worth Rs 127.2 crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA," it added.
The new cancer vaccines are not intended to prevent the onset of cancer in healthy individuals but to stop its recurrence in those already treated, a medical expert said. These are therapeutic cancer vaccines designed to prevent recurrence of the disease in people who already had cancer, not for its prevention in healthy people, said Dr Rajeev Jayadevan, convener of the Research Cell, Kerala State IMA, and chairman of the scientific committee, IMA Cochin. He was speaking at the inaugural session of the second annual conference of the Gastrointestinal Oncology Society (GIOS) here on Saturday. Highlighting the evolution of cancer treatment, including the development of therapeutic cancer vaccines, Jayadevan, in a statement, clarified their purpose. These are a form of immunotherapy, specifically individualised neoantigen therapy, which trains the body's own immune system to recognise and eliminate cancer cells, he said. He also spoke of the modern challenge of information overload a
A regulator has approved a world-first vaccine to protect koalas from chlamydia infections, which are causing infertility and death in the iconic native species that is listed as endangered in parts of Australia. The single-dose vaccine was developed by the University of the Sunshine Coast in Queensland state after more than a decade of research led by professor of microbiology Peter Timms. The research showed the vaccine reduced the likelihood of koalas developing symptoms of chlamydia during breeding age and decreased mortality from the disease in wild populations by at least 65%. The recent approval by Australia's veterinary medicine regulator means the vaccine can now be used in wildlife hospitals, veterinary clinics and in the field to protect the nation's most at-risk koalas, Timms said on Wednesday. We knew a single-dose vaccine with no need for a booster was the answer to reducing the rapid, devastating spread of this disease, which accounts for as much as half of koala .
Mankind Pharma on Monday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial for a molecule under development for the treatment of multiple autoimmune disorders. The molecule is being developed for the treatment of multiple autoimmune disorders, including rheumatoid arthritis, ulcerative colitis, plaque psoriasis, and alopecia. Developed at the Mankind Research Centre, MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile, the drug firm said in a statement. Arjun Juneja, Chief Operating Officer, Mankind Pharma, said the development of MKP11093 is a major milestone representing the company's endeavour to deliver a best-in-class JAK inhibitor that maximises therapeutic potential while addressing the safety concerns associated with conventional approaches. The Phase 1 trial is expected to begin shortly and will evaluate the safety, tolerability, and ...
US Health Secretary Robert F Kennedy Jr, facing pointed bipartisan questioning at a rancorous three-hour Senate committee hearing on Thursday, tried to defend his efforts to pull back Covid-19 vaccine recommendations and explain the turmoil he has created at federal health agencies. Kennedy said the fired CDC director was untrustworthy, stood by his past anti-vaccine rhetoric, and disputed reports of people saying they have had difficulty getting Covid-19 shots. A longtime leader in the anti-vaccine movement, Kennedy has made sweeping changes to agencies tasked with public health policy and scientific research by laying off thousands of workers, firing science advisers and remaking vaccine guidelines. The moves -- some of which contradict assurances he made during his confirmation hearings -- have rattled medical groups and officials in several Democratic-led states, which have responded with their own vaccine advice. Medical groups and several Democrats in Congress have called for